Liothyronine Sodium Mercury Pharmaceuticals Ltd (Liothyronine Sodium)

Liothyronine Sodium acts on the thyroid hormone pathway to replace deficient T3 in various thyroid disorders.

• Hypothyroidism: restores normal metabolic rate by supplementing deficient triiodothyronine.
• Myxedema coma: provides rapid T3 replacement essential for life‑saving management of severe hypothyroid crisis.
• Thyroid hormone replacement therapy: used when oral levothyroxine is inadequate or when a rapid onset of action is required.

• Liothyronine sodium is a synthetic form of the active thyroid hormone triiodothyronine (T3). After intravenous administration, it diffuses into cells and binds to nuclear thyroid hormone receptors (TRα and TRβ). This receptor activation modulates gene transcription, increasing basal metabolic rate, enhancing protein synthesis, and influencing cardiovascular and neurodevelopmental functions. The rapid onset of action reflects its direct availability in the circulation, bypassing the need for peripheral conversion.

Adverse reactions to Liothyronine Sodium can vary in frequency and severity.

Common Side Effects

• Headache: mild to moderate pain after infusion.
• Palpitations: transient rapid heartbeat sensation.
• Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects

• Cardiac arrhythmia: potentially life‑threatening rhythm disturbances.
• Hyperthyroidism: excessive hormone effect causing agitation and weight loss.
• Severe allergic reaction: anaphylaxis with rash, swelling, or respiratory distress.

When using Liothyronine Sodium, certain precautions should be observed to ensure safety and efficacy.

• Cardiac monitoring: assess heart rate and rhythm before and during therapy in patients with known heart disease.
• Dose adjustment: reduce dose in elderly or renal/hepatic impairment.
• Thyroid function tests: monitor serum T3/T4 and TSH levels regularly.
• Drug interactions: review concomitant medications that may affect thyroid hormone activity.
• Pregnancy and lactation: use only if clearly needed, as safety data are limited.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Liothyronine Sodium may interact with several medicines, altering its effect or increasing risk of adverse events.

Major Interactions (Avoid)

• Beta‑blockers: may blunt the cardiovascular response to T3.
• Antithyroid drugs (e.g., methimazole, propylthiouracil): antagonize the hormone’s action.
• Corticosteroids: can increase metabolism of thyroid hormones, reducing efficacy.

Moderate Interactions (Monitor Closely)

• Digoxin: increased risk of arrhythmias due to enhanced cardiac sensitivity.
• Warfarin: thyroid hormones may alter INR, requiring closer monitoring.
• Estrogen‑containing contraceptives: may increase thyroid‑binding globulin, affecting hormone levels.